Value Investors: 1 Global Cannabis Stock to Buy

As the company’s supply chain grows, Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) continues to expand the company’s portfolio of cannabis products for the existing markets in Canada.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cronos Group (TSX:CRON)(NASDAQ:CRON) is an innovative global cannabinoid (CBD) company with international production and distribution across five continents. Cronos Group builds disruptive intellectual property by advancing cannabis research, technology, and product development. The company is in the process of building an iconic brand portfolio that responsibly elevates the consumer experience.

In the United States, Cronos markets and distributes solely U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality channels. In Canada, the company sells a variety of cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under the company’s wellness platform. In addition, dried cannabis and cannabis oils are currently exported for sale to Australia, Germany, and Israel.

Reputable wellness and adult-use brands

The company currently distribute products for the Canadian and non-U.S. international medical cannabis markets. Through the company’s global wellness platform, Cronos produces high-quality cannabis and cannabis products and is focused on building and shaping the global cannabis wellness market and promoting a holistic approach to wellness. The brand’s goal is to improve the lives of others one client at a time.

The company’s premium positioned brand is focused on creating crafted experiences. Cronos’s brands are geared towards a wide range of consumers who are looking for entertainment and fun ways to enhance activities. Cronos also owns lighthearted and playful brands that are focused on offering products that bring friends together and make experiences more enjoyable.

High-quality products

The company develops a preeminent U.S. hemp-derived CBD brand in the U.S. for the adult consumer goods market. Cronos focuses on high-quality U.S. hemp-derived personal care products that are distributed online to approximately 900 premium stores and retail channels.

Cronos recently launched a U.S. hemp-derived CBD brand in the United States. The product stems from the belief that well-being can lead to a better world that’s full of positivity and possibility. It is a belief that extends beyond the products and into everything the brand seeks to do and stand for. The brand intends to distribute products through the mass market focused retail channel in the U.S. in the future.

Diversified global network

Cronos has developed a diversified global sales and distribution network by leveraging established partners for the company’s scale, sales force and market expertise. The company has also built a distribution footprint in Canada through the direct-to-client medical market and the adult-use market, as well as a distribution footprint for hemp-derived consumer products in the U.S. through e-commerce, retail, and hospitality channels.

The company plans to use resources to capitalize on market demand and to further create and scale U.S. hemp-derived consumer products and brands. Cronos intends to access the U.S. mass market focused retail channel in the future. The company currently sells dried cannabis and cannabis extracts directly to clients through Cronos’s wellness platform. Clients are typically sourced through physician and clinic referrals or word-of-mouth recommendations from existing clients.

As the company’s supply chain grows, Cronos continues to expand the company’s portfolio of cannabis products for the existing markets in Canada.

Should you invest $1,000 in OpenText right now?

Before you buy stock in OpenText, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and OpenText wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nikhil Kumar has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »